tirzepatide weight loss percent timeline for Tirzepatide: Breakthrough in Obesity and
Description
Why Choose Dr

For the majority of patients, the heart rate increase associated with GLP-1 receptor agonist therapy is not clinically significant and does not require treatment modification

The Science Behind Results Studies show users can lose approximately 2025% of their body weight over 72 weeks (Jastreboff et al., 2022, New England Journal of Medicine )

In various clinical trials, participants experienced significant quantities of weight loss, averaging a 22.5% reduction of their starting weight over 72 weeks

Moving your tirzepatide treatment to Heally is simple
00656-2/asset/ccb5d465-a316-405d-847e-f889e2a34a2c/main.assets/gr3_lrg.jpg)
For most people, the answer is no
